SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC

SET binding protein 1 (SETBP1) plays crucial roles in various biological processes; however, its involvement in cancer immune checkpoint inhibitor (ICI) treatments has never been studied. In this study, we collected a total of 631 melanoma and 109 non-small cell lung cancer (NSCLC) samples treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Fengxiao, Zhang, Wenjing, Guo, Yuxian, Shi, Fuyan, Kong, Yujia, Tang, Liguo, Han, Caijing, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457048/
https://www.ncbi.nlm.nih.gov/pubmed/37535001
http://dx.doi.org/10.18632/aging.204913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457048/
https://www.ncbi.nlm.nih.gov/pubmed/37535001
http://dx.doi.org/10.18632/aging.204913

Ejemplares similares